# 4D Molecular Therapeutics, Inc.: Form 8-K, filed Feb 3, 2023

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: 8-K
- Filed: 2023-02-03
- Accepted by EDGAR: Feb 2, 2023, 19:08 ET
- Period: 2023-02-02
- Accession: 0001193125-23-023004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000119312523023004/d435190d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000119312523023004/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000119312523023004/d435190d8k.htm

Filed Feb 3, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-023004. Last ingested by Listed: Nov 13, 2026, 16:07 ET. No prices; not investment advice.
